São Paulo, September 22, 2021 – Eurofarma, a multinational pharmaceutical company present across 20 Latin American countries, donated more than 500,000 units of several medicines this month for the victims of the earthquake that affected Haiti, leaving 2,000 dead and 12,000 injured. The initiative, led in Brazil by the Organization of Haitians Living in Brazil (OHVB), relies on the participation of private companies and the donations will be sent to the Dominican Republic, where the Centre Vivre Ensemble Foundation and the Eglise de Dieu Maison de Refuge de Sources Cazeau Mission will centralize the receipt and forward them to Haiti.

Eurofarma deployed a robust Medication Donation program in 2008. Since it is a company value and one of the tools to provide access to and avoid the destruction of medicines fit for use, Eurofarma undertakes full payment of taxes and donates medicines with an expiration date of equal to or less than 6 months to different non-governmental organizations and health institutions that work with vulnerable populations. The cause in favor of the Haitians mobilized dozens of employees to facilitate the donation of a large amount of medicine in record time.

For Maria del Pilar Muñoz, Eurofarma’s Vice President of New Businesses and Sustainability, the fact of being the only Brazilian pharmaceutical company with regional operations reinforced even further the solidarity with the country and the need to help in a humanitarian way. “We have a strong presence in Latin America and are committed to being close to the demands of the region, contributing to the supply and access to medicines. In this moment of so much fragility and pain, being able to help these people, for whom we feel such sympathy, is a reason to be proud. In all, we have allocated more than 500,000 units of medicines that will be very important to meet this exceptional demand. The initiative also expands and reinforces our social commitment,” she concludes.

The donated products include antibiotics, anti-inflammatory drugs, and antiseptics, including medicines exclusively for hospital use and for fighting Covid-19.

Humanitarian aid in times of Covid-19

Since the beginning of the pandemic, Eurofarma has made donations that already amount to BRL 62 million, considering the delivery of staple food baskets, PPE, sanitizer gel, financial resources to expand hospital beds, maintenance of oncologic patients’ treatment, and more than 800,000 units of medicines to health institutions throughout Brazil. 

It is worth remembering that, since March 2021, the company, along with other private sector companies, has committed to supporting the Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP) in hiring health professionals to care for patients infected with the coronavirus. 

Eurofarma does not rule out the possibility of increasing the resources for humanitarian aid during the year and, should the private sector be called upon, the company will be prepared to make its contribution in the acquisition of vaccines against Covid-19.

About Eurofarma Group 

As the first multinational pharmaceutical enterprise with 100% Brazilian capital, the Eurofarma Group has been operating in the pharmaceutical industry since its establishment in 1972, producing and marketing innovative healthcare products and services to improve people’s quality of life. A very diversified company, Eurofarma operates in all major segments, such as Prescription, Non-Prescription, Generic, Hospital and Oncology Drugs. In Brazil alone, it offers more than 430 products, serves all medical specialties, and covers upwards of 200 therapeutic classes, accounting for 80% of the total market.

The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in six more Latin American countries. Reported net sales totaled BRL 5.7 billion in 2020 and the Group employs over 7,600 people.

EUROFARMA IN SOCIAL MEDIA
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma | Twitter: @eurofarma
YouTube: @eurofarmalab